scholarly article | Q13442814 |
P2093 | author name string | Hamm B | |
Fischer T | |||
Braun J | |||
Sieper J | |||
Bollow M | |||
Backhaus M | |||
Reisshauer H | |||
P2860 | cites work | The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy | Q34016674 |
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis | Q34058697 | ||
Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study | Q39463480 | ||
Clinical History as a Screening Test for Ankylosing Spondylitis | Q39812250 | ||
Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? | Q40375297 | ||
The sacroiliac joint in the spondyloarthropathies. | Q41157885 | ||
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. | Q50913336 | ||
Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. | Q52290112 | ||
Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. | Q53007008 | ||
Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging. | Q53013040 | ||
Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients | Q72044965 | ||
P4510 | describes a project that uses | magnetic resonance imaging | Q161238 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 135-140 | |
P577 | publication date | 2000-02-01 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging | |
P478 | volume | 59 |
Q84308912 | 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis |
Q49119264 | A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations |
Q46439316 | Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis |
Q42616837 | Adalimumab for the treatment of ankylosing spondylitis |
Q34994482 | Advances in the understanding of entheseal inflammation |
Q35554475 | Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems |
Q35555515 | Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis |
Q61628504 | Ankylosierende Spondylitis |
Q54165668 | Ankylosing spondylitis |
Q39185886 | Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. |
Q35585432 | Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response |
Q88013479 | Ankylosing spondylitis monocyte-derived macrophages express increased level of A2A adenosine receptor and decreased level of ectonucleoside triphosphate diphosphohydrolase-1 (CD39), A1 and A2B adenosine receptors |
Q24675044 | Ankylosing spondylitis: an overview |
Q40409369 | Anti-TNF agents for the treatment of spondyloarthropathies |
Q37729028 | Anti-TNF-alpha therapy with infliximab in spondyloarthritides |
Q51058288 | Assessment of active and inactive sacroiliitis in patients with ankylosing spondylitis using quantitative dynamic contrast-enhanced MRI. |
Q86391201 | Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging |
Q56899371 | Biomarkers in spondyloarthritis |
Q38593977 | Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts |
Q47144866 | Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis |
Q33520660 | Bone marrow edema: definition, diagnostic value and prognostic value |
Q45299337 | Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort |
Q48931896 | Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints |
Q33390403 | Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study |
Q37279934 | Clinical observations programme in SpA: disease parameters, treatment options and practical management issues |
Q52710782 | Clinical utility of eco-color-power Doppler ultrasonography and contrast enhanced magnetic resonance imaging for interpretation and quantification of joint synovitis: a review. |
Q35605658 | Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis |
Q53340748 | Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study. |
Q34108703 | Cytokines and the immunopathology of the spondyloarthropathies |
Q61628490 | DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen |
Q64239345 | Deregulation of microRNA expression in monocytes and CD4 T lymphocytes from patients with axial spondyloarthritis |
Q39874212 | Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial |
Q51249813 | Diffusion-weighted imaging is a sensitive biomarker of response to biologic therapy in enthesitis-related arthritis. |
Q35555116 | Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis |
Q95725541 | Effect of Icariin on apoptosis and expression of Fas, Fas ligand, B cell lymphoma, and Bcl-2-associated X protein in CD4+ T lymphocytes from patients with ankylosing spondylitis |
Q24674877 | Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis |
Q40204477 | Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients |
Q38068578 | Emerging drugs for axial spondyloarthritis including ankylosing spondylitis |
Q26775660 | Enthesopathies and enthesitis. Part 2: Imaging studies |
Q51534462 | Evaluation of MR imaging guided steroid injection of the sacroiliac joints for the treatment of children with refractory enthesitis-related arthritis. |
Q44616895 | Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies |
Q42597088 | Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. |
Q33923744 | Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation |
Q38465941 | Gene expression profiling analysis of patients with ankylosing spondylitis |
Q41101834 | Genetic and Functional Associations with Decreased Anti-inflammatory Tumor Necrosis Factor Alpha Induced Protein 3 in Macrophages from Subjects with Axial Spondyloarthritis |
Q52853158 | Granulation Tissue Eroding the Subchondral Bone Also Promotes New Bone Formation in Ankylosing Spondylitis. |
Q46646694 | High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis |
Q36171850 | High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone |
Q56957220 | Histomorphologic and histomorphometric characteristics of zygapophyseal joint remodeling in ankylosing spondylitis |
Q37121649 | How does imaging help the clinician in the evaluation and management of spondyloarthritis? |
Q46043893 | IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells |
Q49712215 | Identification of potential target genes for ankylosing spondylitis treatment |
Q37356387 | Imaging in rheumatology: reconciling radiology and rheumatology |
Q35688985 | Imaging in spondyloarthropathies |
Q50109015 | Imaging of the sacroiliac joints |
Q42290440 | Immunohistological analysis of active sacroiliitis in patients with axial spondyloarthritis |
Q35637293 | Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases |
Q91894574 | Increased BMPR1A Expression Enhances the Adipogenic Differentiation of Mesenchymal Stem Cells in Patients with Ankylosing Spondylitis |
Q80216692 | Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis |
Q38070027 | Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective |
Q36210882 | Infliximab for the treatment of ankylosing spondylitis |
Q35637051 | Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. |
Q47710797 | M2 polarization of monocytes in ankylosing spondylitis and relationship with inflammation and structural damage |
Q37228838 | MRI in psoriatic arthritis: insights into pathogenesis and treatment response |
Q22000866 | Magnetic resonance imaging in psoriatic arthritis: a review of the literature |
Q36577527 | Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies |
Q77641935 | Methotrexate in the treatment of ankylosing spondylitis |
Q34560574 | New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy. |
Q35164736 | Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides |
Q26777906 | Old and new treatment targets in axial spondyloarthritis |
Q42604065 | Opinion: Perspectives on imaging in axial spondyloarthritis |
Q38109578 | Osteoimmunology and bone homeostasis: relevance to spondyloarthritis |
Q99564754 | Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis |
Q74531640 | Pathogenesis of reactive arthritis |
Q37516572 | Progress in spondylarthritis. Spondyloarthritis: lessons from imaging |
Q37014104 | Psoriatic disease--from skin to bone |
Q61628518 | Rheumatoid arthritis of the shoulder joint: Comparison of conventional radiography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging |
Q38014263 | Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature |
Q36638774 | Severe bone marrow edema on sacroiliac joint MRI increases the risk of low BMD in patients with axial spondyloarthritis |
Q36394657 | Simultaneous Quantification of Bone Edema/Adiposity and Structure in Inflamed Bone Using Chemical Shift-Encoded MRI in Spondyloarthritis |
Q37279373 | Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics |
Q40577128 | Synovitis in spondyloarthritides |
Q57673802 | T-cell responses to versican in ankylosing spondylitis |
Q37353874 | The efficacy and safety of rituximab in a patient with rheumatoid spondylitis |
Q37918963 | The impact of MRI on the clinical management of inflammatory arthritides. |
Q36519068 | The treatment of the rheumatological manifestations of the inflammatory bowel diseases |
Q24806367 | Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches |
Q36245711 | Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides |
Q34071316 | Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences |
Q34967507 | Treatment trials in ankylosing spondylitis: current and future considerations. |
Q36960221 | Undifferentiated spondyloarthritis: a global perspective |
Q36365524 | Vertebral body corner oedema vs gadolinium enhancement as biomarkers of active spinal inflammation in ankylosing spondylitis. |
Q83350596 | [Bone marrow edema in magnetic resonance imaging. A misleading term?] |
Q84600024 | [Effectiveness of biological agents in ankylosing spondylitis] |
Q80404389 | [Epidemiology and prognostic aspects of ankylosing spondylitis] |
Q52920765 | [Immunopathology of ankylosing spondylitis and other spondyloarthritides]. |
Q83350621 | [MRI examinations for axial and peripheral spondyloarthritis] |
Q52943546 | [Magnetic resonance tomography of sacroiliitis: anatomy, histological pathology, MR-morphology, and grading]. |
Q81376497 | [Modern treatment of ankylosing spondylitis] |
Q84600865 | [Sacroiliac joints: osteoarthritis or arthritis] |
Q79314615 | [Spondylarthritides] |
Search more.